Literature DB >> 22331505

Spontaneous ocular and neurologic deficits in transgenic mouse models of multiple sclerosis and noninvasive investigative modalities: a review.

Archana A Gupta1, Di Ding, Richard K Lee, Robert B Levy, Sanjoy K Bhattacharya.   

Abstract

Multiple sclerosis (MS) is an autoimmune, inflammatory, neurodegenerative, demyelinating disease of the central nervous system, predominantly involving myelinated neurons of the brain, spinal cord, and optic nerve. Optic neuritis is frequently associated with MS and often precedes other neurologic deficits associated with MS. A large number of patients experience visual defects and have abnormalities concomitant with neurologic abnormalities. Transgenic mice manifesting spontaneous neurologic and ocular disease are unique models that have revolutionized the study of MS. Spontaneous experimental autoimmune encephalomyelitis (sEAE) presents with spontaneous onset of demyelination, without the need of an injectable immunogen. This review highlights the various models of sEAE, their disease characteristics, and applicability for future research. The study of optic neuropathy and neurologic manifestations of demyelination in sEAE will expand our understanding of the pathophysiological mechanisms underlying MS. Early and precise diagnosis of MS with different noninvasive methods has opened new avenues in managing symptoms, reducing morbidity, and limiting disease burden. This review discusses the spectrum of available noninvasive techniques, such as electrophysiological and behavioral assessment, optical coherence tomography, scanning laser polarimetry, confocal scanning laser ophthalmoscopy, pupillometry, magnetic resonance imaging, positron emission tomography, gait, and cardiovascular monitoring, and their clinical relevance.

Entities:  

Mesh:

Year:  2012        PMID: 22331505      PMCID: PMC3317416          DOI: 10.1167/iovs.11-8351

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  106 in total

Review 1.  Electrophysiological assessment of optic nerve disease.

Authors:  G E Holder
Journal:  Eye (Lond)       Date:  2004-11       Impact factor: 3.775

Review 2.  Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis.

Authors:  Tjalf Ziemssen
Journal:  J Neurol       Date:  2005-11       Impact factor: 4.849

3.  Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor.

Authors:  H Waldner; M J Whitters; R A Sobel; M Collins; V K Kuchroo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

Review 4.  The pathology of MS: new insights and potential clinical applications.

Authors:  Sean J Pittock; Claudia F Lucchinetti
Journal:  Neurologist       Date:  2007-03       Impact factor: 1.398

5.  The reproducibility of binocular pattern reversal visual evoked potentials: a single subject design.

Authors:  Tessa B Mellow; Alki Liasis; Ruth Lyons; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2011-03-25       Impact factor: 2.379

6.  Somatosensory evoked potentials following tongue stimulation in normal subjects and patients with lesions of the afferent trigeminal system.

Authors:  E Altenmüller; C P Cornelius; U W Buettner
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1990 Nov-Dec

Review 7.  Autoimmune T cell responses in the central nervous system.

Authors:  Joan Goverman
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

8.  Demyelination in a transgenic mouse: a model for multiple sclerosis.

Authors:  F G Mastronardi; C A Ackerley; L Arsenault; B I Roots; M A Moscarello
Journal:  J Neurosci Res       Date:  1993-10-15       Impact factor: 4.164

9.  Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice.

Authors:  R S Johnson; J C Roder; J R Riordan
Journal:  J Neurochem       Date:  1995-03       Impact factor: 5.372

10.  Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease.

Authors:  Jian Luo; Peggy Ho; Lawrence Steinman; Tony Wyss-Coray
Journal:  J Neuroinflammation       Date:  2008-02-01       Impact factor: 8.322

View more
  1 in total

1.  Deimination restores inner retinal visual function in murine demyelinating disease.

Authors:  Mabel Enriquez-Algeciras; Di Ding; Fabrizio G Mastronardi; Robert E Marc; Vittorio Porciatti; Sanjoy K Bhattacharya
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.